LABORATORIOS FARMACEUTICOS ROVI, S.A. «...1112131415...» Page 13 out of 19 17/12/2021 12:37 LABORATORIOS FARMACEUTICOS ROVI, S.A. On business and financial situation The Company reports that the Committee for Medical Products for Human Use (CHMP) has issued a positive opinion on Okedi® (Risperidone ISM®) for the treatment for schizophrenia. Register number: 13249 13/12/2021 11:11 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 6 December 2021 and 10 December 2021. Register number: 13131 06/12/2021 12:05 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 29 November 2021 and 3 December 2021. Register number: 13073 29/11/2021 11:04 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 22 November 2021 and 26 November 2021 Register number: 12929 22/11/2021 10:38 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 15 November 2021 and 19 November 2021. Register number: 12840 16/11/2021 15:16 LABORATORIOS FARMACEUTICOS ROVI, S.A. Liquidity and counterparty agreements The Company informs of the termination of the Liquidity Agreement Register number: 12785 16/11/2021 07:35 LABORATORIOS FARMACEUTICOS ROVI, S.A. On business and financial situation The Company releases the presentation related to its strategy update because of its 2021 Capital Markets Day Register number: 12774 15/11/2021 13:24 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 5 November 2021 and 12 November 2021. Register number: 12764 05/11/2021 12:38 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted on 3 and 4 November Register number: 12612 03/11/2021 07:40 LABORATORIOS FARMACEUTICOS ROVI, S.A. On business and financial situation The Company releases the first nine months 2021 financial results presentation Register number: 12525 Page 13 out of 19 «...1112131415...»
